CP-547632 hydrochloride is primarily utilized in research settings to study its effects on vascular endothelial growth factor receptor 2 (VEGFR-2) and fibroblast growth factor receptor 1 (FGFR-1). It is often employed in preclinical studies to investigate its potential as an angiogenesis inhibitor, which could be relevant in cancer therapy. Researchers use it to explore its ability to block the signaling pathways that promote tumor growth and blood vessel formation. Additionally, it serves as a tool compound in biochemical assays to understand the mechanisms of tyrosine kinase inhibition and its implications in various diseases. Its applications are largely confined to laboratory experiments aimed at advancing knowledge in targeted cancer treatments and related therapeutic strategies.